Jim Cramer Says Doximity is “Still Too Expensive”

Doximity, Inc. (NYSE:DOCS) is one of the stocks Jim Cramer mentioned in his latest comments. During the lightning round, a caller mentioned that they were not sure if they should sell their position in the stock, and Cramer replied:

“No, no, it’s still too expensive, and I didn’t think the quarter was as good as you think. I was actually surprised that this stock ever got as high as it did. I want to wait on that one. I do not want you to buy it here.”

Photo by Artem Podrez on Pexels

Doximity, Inc. (NYSE:DOCS) operates a digital platform that offers medical professionals tools for collaboration, career management, research updates, documentation, and virtual patient care. A caller asked for Cramer’s opinion on the stock during the May 21 episode, and Cramer remarked:

“That was a bad miss. That was a bad miss, and that’s a high-growth company that had just been building up ahead of steam, and I cannot recommend that company because that was an unfathomable miss, frankly. And I feel very badly about saying that, but I was quite surprised. I cannot get behind that.”

Since the above comment was aired, the company’s stock is up less than 1%.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.